LYON, France, Jan 25, 2010 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that a meeting with the U.S. Food and Drug Administration (FDA) has been scheduled for later this month.
Dec 17, 2009 (GlobeNewswire via COMTEX News Network) -- Secures Two Ablatherm-HIFU Device Sales in Europe Finalizing Additional Sales LYON, France, Dec. 17, 2009 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that two major hospitals in
LYON, France, Dec 16, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that the Company attended the Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee Meeting of the U.S.
Highlights: , Nov 17, 2009 (GlobeNewswire via COMTEX News Network) -- Total revenues increased 19.8% for the first nine months of 2009 -- Ablatherm- HIFU revenue per procedure (RPP) treatments increased 36.7% for the first nine months of 2009 -- Sonolith I-Sys Lithotripter received U.S.
LYON, France, Nov 16, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that Dr. Inderbir S. Gill, professor and chairman of the Department of Urology at the Keck School of Medicine of the University of Southern
LYON, France, Nov 4, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its third quarter 2009 earnings announcement, which will take place on Tuesday, November 17, 2009, before the opening of
LYON, France, Oct 13, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that options contracts corresponding to the underlying EDAP common stock have been approved for listing on the NASDAQ OMX PHLX (PHLX) options
LYON, France, Oct 6, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that the French regulatory organization AFSSAPS has authorized a Phase I clinical study to evaluate High Intensity Focused Ultrasound (HIFU)
